article_metadata: Roxane Mari Mathilde Guerin Cécile Vicier Jochen Walz Nathalie Bonnet Géraldine Pignot Gwenaelle Gravis
article_metadata: 10.3389/fimmu.2022.984132
article_metadata: Front Immunol
article_metadata: 2022 Sep 16;13:984132.
article_metadata: bullous pemphigoid durable response immunotherapy late adverse event renal cell carcinoma
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/36189265/
article_metadata: Carcinoma, Renal Cell / drug therapy Kidney Neoplasms / drug therapy Kidney Neoplasms / pathology Pemphigoid, Bullous / chemically induced Pemphigoid, Bullous / diagnosis Pemphigoid, Bullous / drug therapy
article_metadata: Carcinoma, Renal Cell / drug therapy Kidney Neoplasms / drug therapy Kidney Neoplasms / pathology Pemphigoid, Bullous / chemically induced Pemphigoid, Bullous / diagnosis Pemphigoid, Bullous / drug therapy Case Reports Aged Humans Immune Checkpoint Inhibitors Male Nivolumab / adverse effects Immune Checkpoint Inhibitors Nivolumab
article_metadata: PMC9524245
article_metadata: 36189265
article_metadata: Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report
article_metadata: 2022